Emergent BioSolutions | Bénéfice Avant Impôts



Pre Tax Profit Changement Date
Acadia Pharmaceuticals USD 27.78M 133.31M 2025-03
ALKERMES USD 443.75M 333.52M 2024-12
Alnylam Pharmaceuticals USD -41596000 152.36M 2025-03
Amarin USD -13630000 197K 2025-03
ANI Pharmaceuticals USD 19.99M 33.75M 2025-03
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Exact Sciences USD -100991000 774.97M 2025-03
Exelixis USD 205.69M 20.92M 2025-03
Glaxosmithkline USD 1.66B 1.78B 2024-12
Ionis Pharmaceuticals USD -147000000 40M 2025-03
Ironwood Pharmaceuticals USD 17.37M 4.14M 2024-09
Lonza CHF 624M 197M 2024-12
Merck USD 5.22B 114M 2024-12
Moderna USD -964000000 220M 2025-03
Myriad Genetics USD 6.2M 2.1M 2024-12
Neurocrine Biosciences USD 162.6M 27.7M 2024-12
Pacira USD 8.71M 16.82M 2025-03
Pfizer USD 4.44B 2.36B 2024-12
PTC Therapeutics USD -94699000 3.29M 2024-12
Sanofi EUR 2.16B 20M 2025-03
Sarepta Therapeutics USD -383518000 555.26M 2025-03
United Therapeutics USD 423.5M 27M 2025-03



Emergent BioSolutions Bénéfice Avant Impôts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.